650 related articles for article (PubMed ID: 2499419)
21. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
Takigawa M; Verma AK; Simsiman RC; Boutwell RK
Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752
[TBL] [Abstract][Full Text] [Related]
22. Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Persons D; Slepetis RJ; Taylor D; Bartolome J
Teratology; 1984 Oct; 30(2):211-24. PubMed ID: 6208628
[TBL] [Abstract][Full Text] [Related]
23. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
[TBL] [Abstract][Full Text] [Related]
24. Role of polyamines in estradiol-induced growth of human breast cancer cells.
Lima G; Shiu RP
Cancer Res; 1985 Jun; 45(6):2466-70. PubMed ID: 3921243
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic features of breast cancer cells overexpressing ornithine-decarboxylase.
Manni A; Wechter R; Wei L; Heitjan D; Demers L
J Cell Physiol; 1995 Apr; 163(1):129-36. PubMed ID: 7896889
[TBL] [Abstract][Full Text] [Related]
26. Hexachlorobenzene-induced early changes in ornithine decarboxylase and protein tyrosine kinase activities, polyamines and c-Myc, c-Fos and c-Jun proto-oncogenes in rat liver.
Randi AS; Hernandez S; Alvarez L; Sanchez M; Schwarcz M; Kleiman d Pisarev DL
Toxicol Sci; 2003 Dec; 76(2):291-8. PubMed ID: 14600289
[TBL] [Abstract][Full Text] [Related]
27. Effect of tamoxifen and alpha-difluoromethylornithine on clones of nitrosomethylurea-induced rat mammary tumor cells grown in soft agar culture.
Manni A; Wright C
Cancer Res; 1983 Mar; 43(3):1084-6. PubMed ID: 6402297
[TBL] [Abstract][Full Text] [Related]
28. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis.
Uchida K; Seidenfeld J; Rademaker A; Oyasu R
Cancer Res; 1989 Oct; 49(19):5249-53. PubMed ID: 2504487
[TBL] [Abstract][Full Text] [Related]
30. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
31. Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
Oredsson SM; Deen DF; Marton LJ
Cancer Res; 1982 Apr; 42(4):1296-9. PubMed ID: 6800651
[TBL] [Abstract][Full Text] [Related]
32. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
[TBL] [Abstract][Full Text] [Related]
33. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine.
Gerner EW; Garewal HS; Emerson SS; Sampliner RE
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):325-30. PubMed ID: 8061581
[TBL] [Abstract][Full Text] [Related]
35. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
[TBL] [Abstract][Full Text] [Related]
36. Antizyme delays the restoration by spermine of growth of polyamine-deficient cells through its negative regulation of polyamine transport.
He Y; Suzuki T; Kashiwagi K; Igarashi K
Biochem Biophys Res Commun; 1994 Aug; 203(1):608-14. PubMed ID: 8074711
[TBL] [Abstract][Full Text] [Related]
37. Epidermal keratinocytes actively maintain their intracellular polyamine levels.
Roseeuw DI; Marcelo CL; Rhodes LM; Voorhees JJ
Cell Tissue Kinet; 1983 Sep; 16(5):493-504. PubMed ID: 6192925
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
39. In vivo inhibition of polyamine biosynthesis and growth in tobacco ovary tissues.
Slocum RD; Galston AW
Plant Cell Physiol; 1985; 26(8):1519-26. PubMed ID: 11539696
[TBL] [Abstract][Full Text] [Related]
40. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]